Danielle Glanding, Registered Nurse - Case Management Medicare: Not Enrolled in Medicare Practice Location: 3210 Peters Corner Rd, Marydel, MD 21649 Phone: 410-763-6406 |
News Archive
Trubion Pharmaceuticals, Inc. today announced the acceptance of two Phase 1 data presentations on SBI-087 (PF-05230895) at the 2010 annual congress of the European League Against Rheumatism (EULAR) in Rome, Italy. Presentations will include promising data from a Phase 1 study of SBI-087 for the treatment of rheumatoid arthritis (RA) and a Phase 1 study of SBI-087 for the treatment of systemic lupus erythematosus (SLE). Copies of both abstracts are available at http://www.eular.org. SBI-087 is Trubion's next-generation CD20-directed small modular immunopharmaceutical (SMIP™) product candidate and is being developed in collaboration with Pfizer.
New research from Rice University, Baylor College of Medicine (BCM) and the Puget Sound Blood Center (PSBC) has revealed how stresses of flow in the small blood vessels of the heart and brain could cause a common protein to change shape and form dangerous blood clots.
Women who are current and former welfare recipients suffer a whole host of health problems - and getting a job doesn't always help matters.
According to a new study, an ultrasonic vessel-sealing device can improve patient outcomes by reducing the incidence of thoracotomy conversion for VATS/robotic anatomical lung resection.
Four Senators addressed the hundreds of home care and hospice providers today that have come to our nation's capitol to keep the fight alive for the critical, high-value, high-quality care that is offered to millions of vulnerable citizens in this country.
› Verified 5 days ago